LORAZEPAM
LEADING · LORAZEPAM
Open FDA's page for this record- Application number
- ANDA078203
- Sponsor name
- LEADING
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20070730
- Products
- Product number
- 003
- Reference drug
- No
- Brand name
- LORAZEPAM
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- LORAZEPAM
- Strength
- 2MG
- Product number
- 001
- Reference drug
- No
- Brand name
- LORAZEPAM
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- LORAZEPAM
- Strength
- 0.5MG
- Product number
- 002
- Reference drug
- No
- Brand name
- LORAZEPAM
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- LORAZEPAM
- Strength
- 1MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA078203
- Brand name
- LORAZEPAM
- Generic name
- LORAZEPAM
- Manufacturer name
- Leading Pharma, LLC
- Product NDC
- 69315-904, 69315-905, 69315-906
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LORAZEPAM
- RxCUI
- 197900, 197901, 197902
- SPL ID
- 40249bb6-0d25-4b2f-aa4b-85c15af6bf8b
- SPL set ID
- 5ca13415-4b77-4131-a9d2-6db26bc49167
- Package NDC
- 69315-904-01, 69315-904-05, 69315-904-10, 69315-905-01, 69315-905-05, 69315-905-10, 69315-906-01, 69315-906-05, 69315-906-10
- Nui
- N0000175694, M0002356
- Pharm class epc
- Benzodiazepine [EPC]
- Pharm class cs
- Benzodiazepines [CS]
- UNII
- O26FZP769L
